Action A287410 JEISYS MEDICAL INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Jeisys Medical Inc.

Actions

A287410

KR7287410005

Cours en clôture Korea S.E.
Autres places de cotation
 00:00:00 19/04/2024 		Varia. 5j. Varia. 1 janv.
12 020 KRW +1,95 % Graphique intraday de Jeisys Medical Inc. +20,32 % +14,59 %
11/04 AVAVA annonce un partenariat de distribution exclusif avec Jeisys Medical Inc. pour la Corée et le Japon CI
2023 Jeisys Medical Inc. (KOSDAQ:A287410) annonce un rachat d'actions pour une valeur de 10 000 millions KRW. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
AVAVA Announces Exclusive Distribution Partnership with Jeisys Medical Inc. for Korea and Japan
AVAVA, LLC announced that it expects to receive $14.999999 million in funding from Jeisys Medical Inc.
Tranche Update on Jeisys Medical Inc.'s Equity Buyback Plan announced on May 15, 2023.
Tranche Update on Jeisys Medical Inc.'s Equity Buyback Plan announced on May 15, 2023.
Jeisys Medical Inc.'s Equity Buyback announced on May 15, 2023, has closed with 1,075,838 shares, representing 1.42% for KRW 10,000.85 million.
Imeik Technology Wins Exclusive Rights to Distribute Jeisys’ Aesthetic Equipment in China
Tranche Update on Jeisys Medical Inc.'s Equity Buyback Plan announced on May 15, 2023.
Jeisys Medical Inc. announces an Equity Buyback.
Jeisys Medical Inc. authorizes a Buyback Plan.
Jeisys Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Cynosure KK Enters into Distribution Partnership with Jeisys Medical KK in Japan
Jeisys Medical Inc.(KOSDAQ:A287410) added to S&P Global BMI Index
SACCI Bio Co., Ltd. announced that it expects to receive KRW 2.85 billion in funding from Jeisys Medical Inc.
Jeisys Medical Inc. completed the acquisition of Yuanta 3 SPECIAL PURPOSE ACQUISITION CO., LTD. from Alliance Capital Partners Co., Ltd. and others in a reverse merger transaction.
Jeisys Medical Inc. signed a contract to acquire Yuanta 3 SPECIAL PURPOSE ACQUISITION CO., LTD. from Alliance Capital Partners Co., Ltd. and others for approximately KRW 300 billion in a reverse merger transaction.
Jeisys Medical Inc. announced that it has received KRW 4.00043853 billion in funding from BNH Investment LLC, DAYLI Partners Co., Ltd., LSK Investment
Jeisys Medical Inc. announced that it expects to receive KRW 4.00043853 billion in funding from BNH Investment LLC, DAYLI Partners, LSK Investment
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action A287410
  4. Actualités Jeisys Medical Inc.
  5. Autres langues